Historical record - last NADAC publication: 9/22/2016
Product Information
TEMODAR 180 MG CAPSULE is a brand product labeled by Merck Sharp & Dohme LLC, priced at $634.6595 per EA under NDC 00085143003. Its NADAC has been published 149 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the Temozolomide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
180 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00085143003
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
9/22/2016
Active Ingredients
TEMOZOLOMIDEApproval Type
New Drug (NDA)
FDA Application
NDA021029On Market Since
8/11/1999
Pharmacological Classes
Price Statistics
The NADAC for TEMODAR 180 MG CAPSULE has been published 149 times since Nov 28, 2013, and over the history we have for it it has risen 62.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $634.6595 per EA |
|---|---|
| All-time high | $634.6595 (Sep 28, 2016) |
| All-time low | $390.7900 (Nov 28, 2013) |
| Median price | $506.0844 |
| Average price | $492.7929 |
| Largest weekly change | +9.0% (Sep 24, 2014) |
| Weeks tracked | 149 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 97% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TEMODAR 180 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TEMODAR 180 MG CAPSULE, manufactured by Merck Sharp & Dohme LLC, is $634.6595 per EA (NDC 00085143003), effective Sep 28, 2016.
How has the price of TEMODAR 180 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TEMODAR 180 MG CAPSULE has risen 62.4%. It has been tracked across 149 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TEMODAR 180 MG CAPSULE?
Since Nov 28, 2013, the NADAC for TEMODAR 180 MG CAPSULE has ranged from a low of $390.7900 (Nov 28, 2013) to a high of $634.6595 (Sep 28, 2016), with a median of $506.0844 per EA.
Are there cheaper alternatives to TEMODAR 180 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, TEMOZOLOMIDE 180 MG CAPSULE, is $21.4132 per EA — about 97% below TEMODAR 180 MG CAPSULE.
Who manufactures TEMODAR 180 MG CAPSULE?
TEMODAR 180 MG CAPSULE (NDC 00085143003) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification